Skip to main content
EMDF logo

E Med Future, Inc. (EMDF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0033 $0.00 (0.00%)
Vol: 6.0K| 52-wk range: $0.0033 – $0.008
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

E Med Future, Inc. (EMDF) trades at $0.0033. E Med Future, Inc. specializes in manufacturing safety devices aimed at reducing accidental hypodermic needlestick injuries. Sector: Communication services.

Price as of · Last analyzed: Jun 14, 2026
E Med Future, Inc. specializes in manufacturing safety devices aimed at reducing accidental hypodermic needlestick injuries. With innovative products like NeedleZap, the company addresses critical safety concerns in healthcare and related sectors.

Analyst Coverage for EMDF: EMDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the EMDF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

E Med Future, Inc. (EMDF) Media & Communications Profile

CEOGary G. Kompothecras
Employees2
HeadquartersSarasota, United States
IPO Year2003

E Med Future, Inc. is a niche player in the healthcare sector, focusing on innovative safety devices that mitigate the risks associated with hypodermic needlestick injuries, catering to various professional sectors including healthcare and law enforcement.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for EMDF?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

E Med Future, Inc. operates in a specialized segment of the healthcare market with a focus on safety devices aimed at reducing needlestick injuries, a significant concern in medical environments. The company's innovative products, particularly NeedleZap, have the potential to capture a growing market as awareness of safety in healthcare increases. With a gross margin of 65.8%, E Med Future demonstrates strong profitability potential, although it currently faces challenges reflected in a profit margin of -182.1%. The ongoing expansion of healthcare services and an increasing emphasis on safety protocols present growth catalysts for the company. Additionally, the diversification of its product offerings to include devices for various sectors enhances its market appeal. However, the company must navigate risks associated with limited resources, given its small employee base of two, which may impact its ability to scale operations effectively. The need for strategic partnerships and potential funding will be crucial for sustaining growth and addressing market needs.

Based on FMP financials and quantitative analysis

EMDF Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market Cap: $0.00B indicates the company's current valuation in the OTC market.

  • Profit Margin: -182.1% reflects significant challenges in achieving profitability.
  • Gross Margin: 65.8% demonstrates strong potential for profitability if operational efficiencies are achieved.
  • Beta: -0.83 suggests lower volatility compared to the broader market, indicating stability in uncertain conditions.
  • Employee Count: 2 highlights the company's small operational scale, which may impact growth capabilities.

Who Are EMDF's Competitors?

EMDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BDX Becton, Dickinson and Company $180.67 +2.19% $49.8B 72 5-pillar
HOLX Hologic, Inc. $76.01 +0.00% $17.0B —
SYK Stryker Corporation $283.35 +2.88% $109B 79 5-pillar
ZNB Zeta Network Group $1.54 +45.28% —
TDIC Dreamland Limited Class A Ordinary Shares $2.14 -3.17% —
NIPG NIP Group Inc. $11.05 -0.90% $10.4M —
DLPN Dolphin Entertainment, Inc. $1.03 -2.83% $13.4M —
LVO LiveOne, Inc. $2.70 +2.66% $29.7M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are EMDF's Key Strengths?

Innovative product offerings focused on safety.

  • Strong gross margin indicating potential profitability.
  • Niche market focus reduces direct competition.

What Are EMDF's Weaknesses?

Small employee base limits operational capacity.

  • Negative profit margin reflects current financial challenges.
  • Limited brand recognition compared to larger competitors.

What Are the Key Risks for EMDF?

Financial-distress signal — its Altman Z-Score of 0.06 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-9.6%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Increased competition from larger medical device manufacturers.
  • Financial challenges reflected in negative profit margins.
  • Regulatory changes that could impact product development timelines.

What Threats Does EMDF Face?

  • Intense competition from established medical device manufacturers.
  • Regulatory changes that could impact product development.
  • Market volatility affecting funding and operational stability.

What Are EMDF's Competitive Advantages?

  • Specialization in safety devices creates a niche market position.
  • Innovative product design enhances competitive differentiation.
  • Focus on regulatory compliance can build trust with healthcare providers.

What Does EMDF Do?

E Med Future, Inc., founded in 1990 and headquartered in Sarasota, US, is dedicated to enhancing safety in medical and related fields through innovative products designed to minimize the risk of accidental hypodermic needlestick injuries. The company’s flagship product, NeedleZap, is engineered to safely disintegrate the sharp portion of a hypodermic needle, significantly reducing the potential for injury among healthcare professionals and other users. In addition to NeedleZap, E Med Future has developed a dental parking station, providing a temporary resting place for hypodermic syringes, and a butterfly needle burner designed for needles not secured to a syringe, particularly useful in IV and kidney dialysis applications. The company’s offerings cater to a diverse clientele, including healthcare professionals, law enforcement and correctional personnel, veterinarians, military personnel, clinical researchers, as well as workers in hospitality and sanitation sectors. This broad market reach underscores E Med Future's commitment to improving safety standards across various industries. Over the years, the company has evolved from its initial focus to become a specialized provider of safety devices, positioning itself as a critical player in the medical devices industry, particularly in the niche of needlestick injury prevention.

What Products and Services Does EMDF Offer?

  • Manufacture safety devices aimed at reducing needlestick injuries.
  • Develop innovative products like NeedleZap that disintegrate hypodermic needles.
  • Create a dental parking station for temporary syringe placement.
  • Produce a butterfly needle burner for IV and kidney dialysis applications.
  • Serve a diverse clientele including healthcare, law enforcement, and military sectors.
  • Focus on enhancing safety standards in various professional environments.

How Does EMDF Make Money?

  • Generate revenue through the sale of safety devices and medical equipment.
  • Target multiple customer segments including healthcare professionals and law enforcement.
  • Leverage product innovation to differentiate offerings in the medical devices market.

What Industry Does EMDF Operate In?

The medical devices industry is experiencing robust growth, driven by increasing healthcare expenditures and a heightened focus on patient safety. Within this landscape, E Med Future, Inc. occupies a niche segment focused on needlestick injury prevention, an area of growing concern as healthcare providers seek to minimize risks associated with needle use. The competitive landscape includes larger firms with extensive resources, yet E Med Future's specialized focus on safety devices positions it uniquely to capitalize on emerging safety regulations and heightened awareness among healthcare professionals.

Who Are EMDF's Key Customers?

  • Healthcare professionals seeking to minimize needlestick injuries.
  • Law enforcement and correctional personnel requiring safe medical practices.
  • Veterinarians needing specialized safety devices for animal care.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

E Med Future, Inc. operates in the Communication Services sector. It is headquartered in Sarasota, US. EMDF has traded publicly since 2003.

ROE -10%

Key Financial Metrics

Return on equity for E Med Future, Inc. stands at -9.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.6%, showing how much profit it generates from its asset base. A current ratio of 1.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -132.2%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9

Financial Health

E Med Future, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.06 places it in the distress zone, a signal of elevated financial risk.

EMDF Financials

Fundamental Snapshot

Return on Equity (TTM)
-9.6%
Current Ratio
1.1

Based on FMP financials and quantitative analysis

EMDF Latest News

No recent news available for EMDF.

EMDF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EMDF.

Price Targets

Wall Street price target analysis for EMDF.

EMDF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EMDF; grades run from A+ (80-100) to F (below 30).

Leadership: Gary G. Kompothecras

CEO

Gary G. Kompothecras has been leading E Med Future, Inc. since its inception in 1990. With a background in healthcare and business management, he has guided the company through various phases of development. His leadership has focused on innovation in safety devices and expanding the company's market reach.

Track Record: Under Gary's leadership, E Med Future has developed key products that address critical safety issues in healthcare. His strategic decisions have positioned the company as a niche provider in the medical devices market, despite its small operational size.

EMDF OTC Market Information

The OTC Other tier is a classification for companies that do not meet the requirements for higher tiers such as OTCQX or OTCQB. This tier typically includes smaller or less established companies, which may have limited financial disclosure and lower trading volumes compared to those on major exchanges.

  • OTC Tier: OTC Other
Liquidity: Trading on the OTC market may present challenges such as lower trading volumes and wider bid-ask spreads, which can affect the ease of buying and selling shares. Investors should be aware of these factors when considering transactions.
OTC Risk Factors:
  • Limited financial disclosure could impact investment decisions.
  • Lower liquidity may lead to difficulties in executing trades.
  • Potential for higher volatility compared to stocks on major exchanges.
Due Diligence Checklist:
  • Verify the company's financial health and operational metrics.
  • Assess the competitive landscape and market positioning.
  • Review product certifications and regulatory compliance.
  • Investigate management's track record and strategic vision.
  • Examine customer feedback and product performance.
Legitimacy Signals:
  • Established history since 1990 indicates longevity in the market.
  • Focus on safety devices aligns with increasing healthcare regulations.
  • Innovative product development reflects commitment to addressing industry needs.

Common Questions About EMDF (Communication Services)

What are the main risks for EMDF?

E Med Future, Inc. faces several risks including intense competition from larger medical device manufacturers that may overshadow its niche offerings.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial metrics are based on available data, which may not fully represent the company's financial health.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis